Turn Therapeutics Inc.
TTRX
$3.98
$0.102.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 496.90K | -- | -- | -- | -- |
| Gross Profit | -496.90K | -- | -- | -- | -- |
| SG&A Expenses | 6.06M | 4.22M | 2.98M | 1.96M | 1.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.85M | 4.48M | 3.24M | 2.24M | 1.76M |
| Operating Income | -6.85M | -4.48M | -3.24M | -2.24M | -1.76M |
| Income Before Tax | -3.65M | -4.25M | -3.01M | -2.13M | -1.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.65 | -4.25 | -3.01 | -2.13 | -1.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.65M | -4.25M | -3.01M | -2.13M | -1.73M |
| EBIT | -6.85M | -4.48M | -3.24M | -2.24M | -1.76M |
| EBITDA | -6.79M | -4.43M | -3.19M | -2.19M | -1.71M |
| EPS Basic | -0.13 | -0.15 | -0.11 | -0.08 | -0.07 |
| Normalized Basic EPS | -0.08 | -0.10 | -0.07 | -0.05 | -0.04 |
| EPS Diluted | -0.13 | -0.15 | -0.11 | -0.08 | -0.07 |
| Normalized Diluted EPS | -0.08 | -0.10 | -0.07 | -0.05 | -0.04 |
| Average Basic Shares Outstanding | 111.09M | 109.60M | 108.27M | 107.28M | 106.57M |
| Average Diluted Shares Outstanding | 111.09M | 109.60M | 108.27M | 107.28M | 106.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |